# FDA Inspection 1258283 - Hybio Pharmaceutical (Wuhan) Co., Ltd. - November 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/hybio-pharmaceutical-wuhan-co-ltd/27928d65-db35-40db-b7b2-cc4c19746c8e
Source feed: FDA_Inspections

> FDA Inspection 1258283 for Hybio Pharmaceutical (Wuhan) Co., Ltd. on November 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258283
- Company Name: Hybio Pharmaceutical (Wuhan) Co., Ltd.
- Inspection Date: 2024-11-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258283 - 2024-11-29](https://www.keypedia.com/records/fda_inspections/hybio-pharmaceutical-wuhan-co-ltd/cfc14de4-2b63-444b-b66f-a1259f9fcbaf)

Company: https://www.keypedia.com/companies/hybio-pharmaceutical-wuhan-co-ltd/39005794-b200-4576-995c-08949aa0bfb7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c